Heart Disease News and Research

Latest Heart Disease News and Research

Study findings on novel ST2 cardiac biomarker to be presented at ACC 2011

A novel cardiac biomarker, ST2, will be highlighted in three presentations at the American College of Cardiology in New Orleans this week.

1 Apr 2011

3M announces acquisition of Zargis Medical assets

3M announced today it has acquired certain assets of Zargis Medical Corp., maker of the only FDA-approved diagnostic software to classify suspected systolic and diastolic heart murmurs.

1 Apr 2011

New Mexico Software annual revenue decreases 5% to $3.48 million

New Mexico Software, Inc. announced today its financial results, reporting annual revenue in 2010 decreased approximately 5% to $3.48 million compared to $3.66 million in 2009.

1 Apr 2011

New research: 'Good cholesterol' can act as special delivery vehicle for cancer destruction

High-density lipoprotein's hauls excess cholesterol to the liver for disposal, but new research suggests "good cholesterol" can also act as a special delivery vehicle of destruction for cancer.

1 Apr 2011

Lance Sandwich Crackers to support JDRF's Walk to Cure Diabetes

Lance Sandwich Crackers is partnering with the Juvenile Diabetes Research Foundation to support the organization's efforts to find better treatments and a cure for type 1 diabetes.

1 Apr 2011

New guidelines to eliminate bloodstream infections in patients with intravenous catheters

New guidelines, released by the Centers for Disease Control and Prevention and the Healthcare Infection Control Practices Advisory Committee outline steps to eliminate bloodstream infections in patients with intravenous catheters, which are among the most deadly and costly healthcare-associated infections.

1 Apr 2011

AngioScore launches AngioSculpt PTA Scoring Balloon Catheters for treatment of PAD

AngioScore, Inc., a developer of novel angioplasty catheters for use in the treatment of cardiovascular disease, today announced the launch of new, longer AngioSculpt PTA Scoring Balloon Catheters for the treatment of peripheral artery disease.

1 Apr 2011

NIH combats obesity epidemic with new strategic research plan

To combat the obesity epidemic, the National Institutes of Health is encouraging diverse scientific investigations through a new Strategic Plan for NIH Obesity Research.

1 Apr 2011

MEDNAX acquires three physician group practices in San Antonio, TX and Miami, FL

MEDNAX, Inc., today announced the acquisition of three separate physician group practices based in San Antonio, TX and Miami, FL, as well as the expansion of new services in Topeka, KS.

1 Apr 2011

OPO staff working with ICU team can help recover more organs from brain dead donors

More than twice as many lungs and nearly 50 percent more kidneys could be recovered for transplant operations if intensive care physicians were to work with organ procurement organization (OPO) coordinators to monitor and manage donor bodies after brain death has occurred, according to an analysis by UPMC and University of Pittsburgh School of Medicine physicians that is now in the online version of the American Journal of Transplantation.

1 Apr 2011

NIH-funded program to focus on obesity complications in low-income mothers

A Michigan State University nursing researcher has been awarded $3.3 million to help low-income mothers who are overweight or obese improve their health by eating well, being active and dealing with stress.

1 Apr 2011

CASE District IV honors MD Anderson's associate vice president with Achievement Award

The Council for Advancement and Support of Education District IV has named Michael C. Frick, associate vice president for development at The University of Texas MD Anderson Cancer Center, the recipient of its 2011 Distinguished Achievement Award.

1 Apr 2011

Diamond Mold joins with University of Utah to raise awareness about heart health

Climbing Mount Everest under any circumstances is extreme, particularly if you're climbing a portion of it with the man who holds the world record for summiting Everest more than any other climber.

1 Apr 2011

Nine state, local organizations to receive NHLBI grant for COPD education initiatives

Nine state and local organizations will receive a total of $383,000 for chronic obstructive pulmonary disease education initiatives, the National Heart, Lung, and Blood Institute, part of the National Institutes of Health, announced today.

1 Apr 2011

UTHealth initiates enrollment in study on promising surgical procedure for management of type 2 diabetes

Physicians at The University of Texas Health Science Center at Houston (UTHealth) have begun enrollment for a pilot study on a promising surgical approach for the management of Type 2 diabetes.

1 Apr 2011

Blue Cross and Blue Shield of Minnesota reports $9 billion revenue for 2010

Blue Cross and Blue Shield of Minnesota and its family of companies (Blue Cross) today announced audited financial results for 2010. The nonprofit health company reported full-year 2010 revenues of $9 billion and an operating margin of 1.4%, which resulted in a net operating income of $127 million. This marks the second consecutive year of positive operating results, following three consecutive years of operating losses from 2006 to 2008.

1 Apr 2011

CorMedix reports encouraging interim results from CRMD001 phase II study in Contrast Induced Acute Kidney Injury

CorMedix Inc., a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiorenal disease, today announced its interim analysis and clinical update for CRMD001.

1 Apr 2011

Sleep apnea along with excessive daytime sleepiness elevates risk of death in older adults

A study in the April 1 issue of the journal SLEEP suggests that the risk of death is more than two times higher in older adults who have sleep apnea and report struggling with excessive daytime sleepiness.

1 Apr 2011

New data confirms antiviral activity of fluvastatin in patients with HCV

New data presented today at the International Liver CongressTM confirm the antiviral activity of fluvastatin -- commonly used as a cholesterol-lowering treatment -- in patients with chronic hepatitis C.

1 Apr 2011

Merck's VICTRELIS phase III study results against HCV presented at EASL annual meeting

Merck, known as MSD outside of the United States and Canada, announced results from several new data analyses from the pivotal Phase III studies evaluating the addition of its investigational oral protease inhibitor VICTRELIS to peginterferon alfa-2b and ribavirin in adult patients with chronic hepatitis C virus genotype 1 infection.

1 Apr 2011

Heart Disease News and Research

Latest Heart Disease News and Research

Study findings on novel ST2 cardiac biomarker to be presented at ACC 2011

3M announces acquisition of Zargis Medical assets

New Mexico Software annual revenue decreases 5% to $3.48 million

New research: 'Good cholesterol' can act as special delivery vehicle for cancer destruction

Lance Sandwich Crackers to support JDRF's Walk to Cure Diabetes

New guidelines to eliminate bloodstream infections in patients with intravenous catheters

AngioScore launches AngioSculpt PTA Scoring Balloon Catheters for treatment of PAD

NIH combats obesity epidemic with new strategic research plan

MEDNAX acquires three physician group practices in San Antonio, TX and Miami, FL

OPO staff working with ICU team can help recover more organs from brain dead donors

NIH-funded program to focus on obesity complications in low-income mothers

CASE District IV honors MD Anderson's associate vice president with Achievement Award

Diamond Mold joins with University of Utah to raise awareness about heart health

Nine state, local organizations to receive NHLBI grant for COPD education initiatives

UTHealth initiates enrollment in study on promising surgical procedure for management of type 2 diabetes

Blue Cross and Blue Shield of Minnesota reports $9 billion revenue for 2010

CorMedix reports encouraging interim results from CRMD001 phase II study in Contrast Induced Acute Kidney Injury

Sleep apnea along with excessive daytime sleepiness elevates risk of death in older adults

New data confirms antiviral activity of fluvastatin in patients with HCV

Merck's VICTRELIS phase III study results against HCV presented at EASL annual meeting

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Heart Disease News and Research

Latest Heart Disease News and Research

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in